ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Ann Thorac Surg 2008;85:1646-1649. doi:10.1016/j.athoracsur.2008.01.020
© 2008 The Society of Thoracic Surgeons

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Igor D. Gregoric
Brian A. Bruckner
William E. Cohn
Saverio La Francesca
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Gregoric, I. D.
Right arrow Articles by Frazier, O.H.
PubMed
Right arrow Articles by Gregoric, I. D.
Right arrow Articles by Frazier, O.H.
Related Collections
Right arrow Mechanical Circulatory Assistance


Original Articles: Adult Cardiac

Clinical Experience With Sternotomy Versus Subcostal Approach for Exchange of the HeartMate XVE to the HeartMate II Ventricular Assist Device

Igor D. Gregoric, MDa,*, Brian A. Bruckner, MDa, Leon Jacob, MDa, Biswajit Kar, MDb, William E. Cohn, MDa, Saverio La Francesca, MDa, O.H. Frazier, MD

a Division of Cardiopulmonary Transplantation, Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, Texas
b Heart Failure Clinic, Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, Texas

Accepted for publication January 9, 2008.

* Address correspondence to Dr Gregoric, Texas Heart Institute, MC 3-147, PO Box 20345, Houston, TX 77225-0345 (Email: epongratz{at}heart.thi.tmc.edu).

Background: Most patients undergoing destination therapy with a HeartMate XVE left ventricular assist device will eventually require pump exchange to continue long-term cardiac support.

Methods: To determine whether left ventricular assist device exchange can be accomplished with low morbidity and mortality, we retrospectively reviewed the records of 14 patients who experienced pump malfunction and subsequently required replacement of their HeartMate XVE left ventricular assist devices with HeartMate II axial-flow pumps. We collected data regarding duration of support and reasons for pump failure, perioperative characteristics, and operative approach.

Results: On average, patients were supported 473 ± 233 days with HeartMate XVE pumps. Seven early patients required both subcostal and sternotomy incisions; 7 later patients had subcostal incisions only. Thirteen patients underwent successful exchange to the HeartMate II; 1 patient died in the operating room. Another patient died in the perioperative period (30-day mortality, 14% [2 of 14]). There were significant differences between the two groups. The patients who required only subcostal incisions had shorter operative times (187 versus 220 minutes; p = 0.04) and required fewer transfused blood products (packed red blood cells, 8.6 versus 28.7 units; p = 0.03; and fresh-frozen plasma, 12.4 versus 30.9 units; p = 0.04). Additionally, the patients with subcostal incisions had shorter postoperative intensive care unit stays (5.3 ± 1.1 versus 8.4 ± 3.1 days for redo sternotomy patients; p = 0.03). Of the survivors, average hospital stay was 22 ± 14 days. Average long-term follow-up was 11.2 ± 7.8 months; 71% (10 of 14) of patients are currently alive.

Conclusions: Exchange of a HeartMate XVE to a HeartMate II can be accomplished with relatively low morbidity and mortality through a subcostal approach.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
A. J. Lodge
Invited commentary.
Ann. Thorac. Surg., May 1, 2008; 85(5): 1650 - 1650.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by The Society of Thoracic Surgeons.